Intrinsic Factor Antibodies(redirected from intrinsic factor blocking antibodies)
Intrinsic Factor Antibodies
Synonym/acronym: IF antibodies, intrinsic factor blocking antibodies.
To assist in the investigation of suspected pernicious anemia.
SpecimenSerum (1 mL) collected in a gold-, red-, or red/gray-top tube. Place separated serum into a standard transport tube within 2 hr of collection.
(Method: Immunoassay) Negative.
Intrinsic factor (IF) is a glycoprotein produced by the parietal cells of the gastric mucosa. IF is required for the normal absorption of vitamin B12 and measurement of circulating antibodies to IF is used to evaluate conditions of vitamin B12 deficiency. There are two types of antibodies: type 1, the more commonly present blocking antibody, and type 2, the binding antibody. The blocking antibody prevents attachment of vitamin B12 at the binding site of IF. Binding antibody combines with either free or complexed IF, inhibiting attachment of the vitamin B12-intrinsic factor complex to ileal receptors. Autoantibodies may also form against parietal cells and can be detected by enzyme immunoassay.
This procedure is contraindicated for
- Assist in the diagnosis of pernicious anemia
- Evaluate patients with decreased vitamin B12 levels
Conditions that involve the production of these blocking and binding autoantibodies
- Megaloblastic anemia
- Pernicious anemia
- Some patients with hyperthyroidism
- Some patients with insulin-dependent (type 1) diabetes
- Recent treatment with methotrexate or another folic acid antagonist can interfere with test results.
- Vitamin B12 injected or ingested within 48 hr of the test invalidates results.
- Failure to follow dietary restrictions before the procedure may cause the procedure to be canceled or repeated.
Nursing Implications and Procedure
- Positively identify the patient using at least two unique identifiers before providing care, treatment, or services.
- Patient Teaching: Inform the patient this test can assist in assessing for anemia.
- Obtain a history of the patient’s complaints, including a list of known allergens, especially allergies or sensitivities to latex. Central nervous system changes have a strong association with pernicious and megaloblastic anemias. Onset of the anemia may occur over a prolonged period of time during which the patient may be unaware of the development of symptoms; ask the patient whether he or she has experienced alterations in sensory organ function such as blurred or other changes in vision, loss of hearing, or changes in how foods taste. Ask the patient if he or she is experiencing dizziness, disorientation, irritability, memory loss, numbness, tingling, or lack of coordination. Ask male patients if they are experiencing impotence.
- Obtain a history of the patient’s gastrointestinal and hematopoietic systems, symptoms, and results of previously performed laboratory tests and diagnostic and surgical procedures.
- Note any recent procedures that can interfere with test results.
- Obtain a list of the patient’s current medications, including herbs, nutritional supplements, and nutraceuticals (see Effects of Natural Products on Laboratory Values).
- Review the procedure with the patient. Inform the patient that specimen collection takes approximately 5 to 10 min. Address concerns about pain and explain that there may be some discomfort during the venipuncture.
- Sensitivity to social and cultural issues, as well as concern for modesty, is important in providing psychological support before, during, and after the procedure.
- Note that there are no food or fluid restrictions unless by medical direction. Administration of vitamin B12, injected, ingested, or administered otherwise (e.g., absorbed by nasal gel or sublingual tablet), should be withheld within 2 wk before testing.
- Potential complications: N/A
- Ensure that vitamin B12 has been withheld within 2 wk before testing.
- Avoid the use of equipment containing latex if the patient has a history of allergic reaction to latex.
- Instruct the patient to cooperate fully and to follow directions. Direct the patient to breathe normally and to avoid unnecessary movement.
- Observe standard precautions, and follow the general guidelines in Patient Preparation and Specimen Collection. Positively identify the patient, and label the appropriate specimen container with the corresponding patient demographics, initials of the person collecting the specimen, date, and time of collection. Perform a venipuncture.
- Remove the needle and apply direct pressure with dry gauze to stop bleeding. Observe/assess venipuncture site for bleeding or hematoma formation and secure gauze with adhesive bandage.
- Promptly transport the specimen to the laboratory for processing and analysis.
- Inform the patient that a report of the results will be made available to the requesting health-care provider (HCP), who will discuss the results with the patient.
- Reinforce information given by the patient’s HCP regarding further testing, treatment, or referral to another HCP. Answer any questions or address any concerns voiced by the patient or family. The anemias associated with vitamin B12 deficiency produce a variety of signs and symptoms that may cause significant distress for the patient and family. Neurological complications may cause personality changes such as irritability, paranoia, disorientation, or delirium. Depending on the family situation, arrangements for social service or home care referrals may be indicated. Suggest ways to help the patient with fine motor deficits to feel greater independence, for example, the patient may have an easier time dressing if clothing without small buttons or hooks is chosen. If the patient has experienced permanent neurological deficits, the HCP may recommend a referral to physical therapy for rehabilitation. Instruct the patient to self-administer a vitamin B12 injection and provide resources for education regarding side effects and interactions with other drugs. Discuss the need for a well-balanced diet, foods that contain vitamin B12, and describe adequate daily fluid volume. Because there is an association between pernicious anemia and increased risk for developing gastric carcinoma, encourage the patient to have regular complete physical examinations.
- Depending on the results of this procedure, additional testing may be performed to evaluate or monitor progression of the disease process and determine the need for a change in therapy. Evaluate test results in relation to the patient’s symptoms and other tests performed.
- Related tests include antibodies antithyroglobulin and antithyroid peroxidase, biopsy bone marrow, CBC, CBC RBC indices, folic acid, and vitamin B12.
- Refer to the Gastrointestinal and Hematopoietic systems tables at the end of the book for related tests by body system.